
ThinkGenetic: Digitally revolutionizing genetic disease identification using electronic health data and proprietary algorithms.
Founded with the mission to digitally revolutionize the identification of genetic diseases, ThinkGenetic leverages electronic health data and proprietary algorithms to shorten the diagnostic journey for patients with underlying genetic conditions. Their core products, FindEHR™ and FindSM™, utilize advanced AI and clinical expertise to precisely identify at-risk patients, aiming to improve early diagnosis and treatment outcomes. ThinkGenetic focuses on the healthcare market, particularly in the realm of rare diseases.
Notable affiliations include recognition from MIT and Horizon, which voted ThinkGenetic as one of the best in the world. The company has achieved significant milestones, including the development of validated algorithms that enhance patient identification accuracy. ThinkGenetic's impact is evident in its contribution to the early diagnosis of rare genetic conditions, thereby potentially improving patient care and reducing healthcare costs.

Probably Genetic

Geneticure
geneticure.com

Invitae
invitae.com

Sivotec Bioinformatics

Emedgene
emedgene.com

Gene Solutions

GeneDx Holdings
genedx.com

Genetica
genetica.asia

My Gene Counsel
mygenecounsel.com

Eureka Genomics
eurekagenomics.com

Genetic Foresight

Geno.Me
yourgeno.me

Allelica
allelica.com

Nest Genomics
nestgenomics.com

Genendeavor
genendeavor.com
Companies similar to ThinkGenetic include Probably Genetic, Geneticure, Invitae and Sivotec Bioinformatics.
ThinkGenetic was founded in 2015.
ThinkGenetic's headquarters is located in Sudbury, MA, US.
ThinkGenetic's most recent funding round was for $1.5M (USD) in February 2019.
As of Feb 19, 2019, ThinkGenetic has raised a total of $1.5M (USD).
ThinkGenetic has 32 employees as of Feb 4, 2024.